Takeda COO Weber Faces Opposition In Vote To Name Him President
This article was originally published in PharmAsia News
Executive Summary
France-born Christophe Weber, a former 17-year executive with British drug maker GlaxoSmithKline, apparently will face the opposition of the family founders of Takeda Pharmaceutical at a shareholder meeting to name him president.